Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors.

Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Abstract Text:

    robert m rzasaRobert M Rzasa,matthew r kallerMatthew R Kaller,gang liuGang Liu,ella magalElla Magal,thomas t nguyenThomas T Nguyen,timothy d osslundTimothy D Osslund,david powersDavid Powers,vincent j santoraVincent J Santora,vellarkad n viswanadhanVellarkad N Viswanadhan,hui-ling wangHui-Ling Wang,xiaoling xiongXiaoling Xiong,wenge zhongWenge Zhong,mark h normanMark H Norman,robert m rzasaRobert M Rzasa,matthew r kallerMatthew R Kaller,gang liuGang Liu,ella magalElla Magal,thomas t nguyenThomas T Nguyen,timothy d osslundTimothy D Osslund,david powersDavid Powers,vincent j santoraVincent J Santora,vellarkad n viswanadhanVellarkad N Viswanadhan,hui-ling wangHui-Ling Wang,xiaoling xiongXiaoling Xiong,wenge zhongWenge Zhong,mark h normanMark H Norman,

    Cyclin-dependent kinase 5 (CDK5) is a serine/threonine kinase that plays a critical role in the early development of the nervous system. Deregulation of CDK5 is believed to contribute to the abnormal phosphorylation of various cellular substrates associated with neurodegenerative disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, and ischemic stroke. Acyclic urea 3 was identified as a potent CDK5 inhibitor and co-crystallographic data of urea 3/CDK2 enzyme were used to design a novel series of 3,4-dihydroquinazolin-2(1H)-ones as CDK5 inhibitors. In this investigation we present our synthetic studies toward this series of compounds and discuss their biological relevance as CDK5 inhibitors.

    Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Publishing Authors By Initials

    rm rzasaRM Rzasa,mr kallerMR Kaller,g liuG Liu,e magalE Magal,tt nguyenTT Nguyen,td osslundTD Osslund,d powersD Powers,vj santoraVJ Santora,vn viswanadhanVN Viswanadhan,hl wangHL Wang,x xiongX Xiong,w zhongW Zhong,mh normanMH Norman,rm rzasaRM Rzasa,mr kallerMR Kaller,g liuG Liu,e magalE Magal,tt nguyenTT Nguyen,td osslundTD Osslund,d powersD Powers,vj santoraVJ Santora,vn viswanadhanVN Viswanadhan,hl wangHL Wang,x xiongX Xiong,w zhongW Zhong,mh normanMH Norman,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Bioorganic & medicinal chemistry

    VOLUME: 15

    Page Numbers: 6574-95

    Journal Abbreviation: Bioorg. Med. Chem.

    ISSN: 0968-0896

    DAY: 25

    MONTH: 07

    YEAR: 2007

    Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9413298

    Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors.

    AFFILIATION: Department of Chemistry Research and Discovery, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1789, USA. rrzasa@amgen.com

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Bioorg Med Chem

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News